Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Winlevi HPA axis suppression in pediatric acne (9-11 years)
NCT02720627Phase 2Completed
- Sponsor
- Cassiopea S.p.A.
- Start
- Oct 2016
- Primary completion
- Mar 2018
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 2 trial of clascoterone in acne vulgaris, sponsored by Cassiopea S.p.A.. Started Oct 2016; status: completed.
02
Drugs
clascoterone
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT02720627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02720627.